Anti-Bcma Car T-Cell Therapy In Myeloma: Updates From Ash 2020

Anti-BCMA CAR T-cell therapy in myeloma: updates from ASH 2020

VJHemOnc – Video Journal of Hematology & HemOnc

ASH 2020 Updates: CAR T Cell Therapies in Multiple Myeloma

Anti-BCMA CAR T-cell therapy for multiple myeloma: latest studies

VJHemOnc – Video Journal of Hematology & HemOnc

The future of anti-BCMA CAR T-cell therapy in myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Anti-BCMA CAR T cell therapy for multiple myeloma

Yi Lin, MD, PhD, on how anti-BCMA CAR-T cell therapy fits into the treatment of RRMM

bb21217: next gen anti-BCMA CAR-T for R/R MM

VJHemOnc – Video Journal of Hematology & HemOnc

Future of anti-BCMA CAR T-cell therapy in myeloma

Meta-analysis: anti-BCMA CAR-T in R/R multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Improving CAR T-cell therapy for myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-Cells Multiple Myeloma: Adam Sperling, MD, PhD

Dana-Farber Cancer Institute

The Promise of Anti-BCMA CAR T-Cell Therapy in MM

LEGEND-2 and CARTITUDE-1: anti-BCMA CAR-T for myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Anti-BCMA CAR T-cells for MM: durable clinical responses with bb2121

VJHemOnc – Video Journal of Hematology & HemOnc

Melissa Alsina, MD, considers the role of anti-BCMA CAR-T cell therapy

Myeloma CAR-T update with Nina Shah

VJHemOnc – Video Journal of Hematology & HemOnc

FHVH-BCMA-T CAR T-cell therapy shows efficacy in R/R myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Phase I/II trial of P-BCMA-101 CAR-T cell therapy in R/R myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Yi Lin, MD, PhD, offers opinion on anti-BCMA CAR-T cell therapy

Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy

International Myeloma Foundation